Seasonal allergies can cause a stuffy nose, runny nose, nose itching, and sneezing.
This medicine was already approved for adults and children ages 12 and older.
Now, younger children with seasonal allergies can use this medicine too. Ryaltris (olopatadine/mometasone) is a nasal spray that combines two different allergy medicines together: olopatadine and mometasone. Olopatadine is an antihistamine that helps block allergy symptoms. Mometasone is a steroid that reduces swelling and inflammation inside the nose. Together, these two medicines help treat troublesome allergy symptoms. Seasonal allergies can affect a child’s sleep, schoolwork, and daily activities. Having both medicines in a single nasal spray helps simplify daily allergy care for children.
Why Was It Approved for Younger Children?
The FDA expanded the approval of Ryaltris based on a 14-day clinical study in 446 children ages 6 to 11 years with seasonal allergies. In the study, half of the children used Ryaltris nasal spray twice a day, while the other half used a placebo spray that contained no active medicine.
What Do Patients and Parents Need to Know?
Ryaltris is used only in the nose. For children ages 6 to 11 years, it is given as one spray in each nostril twice every day. Before using a bottle for the first time, you must prime it by spraying it six times into the air away from the face until a fine mist appears. If the spray has not been used for 14 days or more, prime it again with two sprays. Always shake the bottle well before each use.
